12:00 AM
 | 
Jul 20, 2009
 |  BC Week In Review  |  Company News  |  Sales & Marketing

MiddleBrook sales and marketing update

MiddleBrook launched a co-pay program for 775 mg Moxatag amoxicillin extended-release, once-daily tablets to treat pharyngitis and/or...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >